These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11126205)

  • 1. Effects of the two beta3-agonists, ZD7114 and ZD2079 on 24 hour energy expenditure and respiratory quotient in obese subjects.
    Buemann B; Toubro S; Astrup A
    Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1553-60. PubMed ID: 11126205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ZD7114, a selective beta3-adrenoceptor agonist, on neuroendocrine mechanisms controlling energy balance.
    Savontaus E; Pesonen U; Rouru J; Huupponen R; Koulu M
    Eur J Pharmacol; 1998 Apr; 347(2-3):265-74. PubMed ID: 9653893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on metabolic rate and fuel selection of a selective beta-3 agonist (ICI D7114) in healthy lean men.
    Goldberg GR; Prentice AM; Murgatroyd PR; Haines W; Tuersley MD
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):625-31. PubMed ID: 8574272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of 24-h energy expenditure, substrate utilization and spontaneous physical activity in obesity measured in a respiration chamber.
    Toubro S; Christensen NJ; Astrup A
    Int J Obes Relat Metab Disord; 1995 Aug; 19(8):544-9. PubMed ID: 7489024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men.
    Larsen TM; Toubro S; van Baak MA; Gottesdiener KM; Larson P; Saris WH; Astrup A
    Am J Clin Nutr; 2002 Oct; 76(4):780-8. PubMed ID: 12324291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
    Weyer C; Tataranni PA; Snitker S; Danforth E; Ravussin E
    Diabetes; 1998 Oct; 47(10):1555-61. PubMed ID: 9753292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zeneca ZD7114 acts as an antagonist at beta 3-adrenoceptors in rat isolated ileum.
    Growcott JW; Holloway B; Green M; Wilson C
    Br J Pharmacol; 1993 Dec; 110(4):1375-80. PubMed ID: 7905770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive food stimulants of sympathetic activity: effect on 24-h energy expenditure and fat oxidation.
    Belza A; Jessen AB
    Eur J Clin Nutr; 2005 Jun; 59(6):733-41. PubMed ID: 15870822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of an effect of a novel beta3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study.
    Redman LM; de Jonge L; Fang X; Gamlin B; Recker D; Greenway FL; Smith SR; Ravussin E
    J Clin Endocrinol Metab; 2007 Feb; 92(2):527-31. PubMed ID: 17118998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a novel beta-adrenoceptor agonist (Ro 40-2148) on resting energy expenditure in obese women.
    Haesler E; Golay A; Güzelhan C; Schutz Y; Hartmann D; Jéquier E; Felber JP
    Int J Obes Relat Metab Disord; 1994 May; 18(5):313-22. PubMed ID: 7914795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction.
    Hansen DL; Toubro S; Stock MJ; Macdonald IA; Astrup A
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1016-24. PubMed ID: 10557021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermogenic responsiveness to nonspecific beta-adrenergic stimulation is not related to genetic variation in codon 16 of the beta2-adrenergic receptor.
    Bell C; Stob NR; Seals DR
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E703-7. PubMed ID: 16278251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure.
    Martin CK; Redman LM; Zhang J; Sanchez M; Anderson CM; Smith SR; Ravussin E
    J Clin Endocrinol Metab; 2011 Mar; 96(3):837-45. PubMed ID: 21190985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
    Schiffelers SL; Blaak EE; Saris WH; van Baak MA
    Clin Pharmacol Ther; 2000 May; 67(5):558-66. PubMed ID: 10824635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acid metabolite of ZD7114 is a partial agonist of lipolysis mediated by the rat beta 3-adrenoceptor.
    Mayers RM; Quayle SP; Thompson AJ; Grant TL; Holloway BR
    Eur J Pharmacol; 1996 Jan; 295(2-3):199-205. PubMed ID: 8720584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICI D7114: a novel selective adrenoceptor agonist of brown fat and thermogenesis.
    Holloway BR; Howe R; Rao BS; Stribling D
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):262S-264S. PubMed ID: 1345891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of beta3 adrenergic receptor decreases DNA synthesis in human skin fibroblasts via cyclic GMP/nitric oxide pathway.
    Furlán C; Sterin-Borda L; Borda E
    Cell Physiol Biochem; 2005; 16(4-6):175-82. PubMed ID: 16301818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary tract toxicity in rats following administration of beta 3-adrenoceptor agonists.
    Waghe M; Westwood R; Nunn G; Kalinowski A; Aldridge A
    Toxicol Pathol; 1999; 27(2):165-70. PubMed ID: 10207980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.
    Malinowska B; Schlicker E
    Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-induced sympathetic activity and energy expenditure during acute alpha2-adrenergic antagonism in obese subjects.
    Thalamas C; Galitzky J; Sénard JM; Lafontan M; Montastruc JL; Berlan M; Barbe P
    Int J Obes Relat Metab Disord; 2000 Jun; 24(6):695-700. PubMed ID: 10878675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.